Scott Kollins - Akili Chief Officer
AKLIDelisted Stock | USD 0.43 0.00 0.00% |
Insider
Scott Kollins is Chief Officer of Akili Inc
Phone | 617 313 8853 |
Web | https://www.akiliinteractive.com |
Akili Management Efficiency
The company has return on total asset (ROA) of (0.3662) % which means that it has lost $0.3662 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6806) %, meaning that it created substantial loss on money invested by shareholders. Akili's management efficiency ratios could be used to measure how well Akili manages its routine affairs as well as how well it operates its assets and liabilities.Akili Inc currently holds 15.48 M in liabilities with Debt to Equity (D/E) ratio of 0.79, which is about average as compared to similar companies. Akili Inc has a current ratio of 4.68, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Akili's use of debt, we should always consider it together with its cash and equity.
Similar Executives
Showing other executives | INSIDER Age | ||
Daniel Barton | Forian Inc | 59 | |
Jason Alger | Health Catalyst | 40 | |
Max Wygod | Forian Inc | 36 | |
Jason Jones | Health Catalyst | N/A | |
Jim Grauel | FOXO Technologies | N/A | |
Daniel Burton | Health Catalyst | 49 | |
Jacob Goldberger | Streamline Health Solutions | N/A | |
Amy Sebero | Streamline Health Solutions | N/A | |
John Lorbiecki | Aclarion | 61 | |
Wendy Lucio | Streamline Health Solutions | N/A | |
Michael Vesey | Forian Inc | 62 | |
Jona Raasch | National Research Corp | 65 | |
Tyson Murdock | HealthEquity | 53 | |
Dave Ross | Health Catalyst | N/A | |
Brian Chen | FOXO Technologies | N/A | |
Jon Boumstein | National Research Corp | N/A | |
Paul Horstmeier | Health Catalyst | 63 | |
Steven Sobak | EUDA Health Holdings | 78 | |
Susan Neo | FOXO Technologies | N/A | |
David Terrell | Forian Inc | N/A | |
CPA CPA | National Research Corp | 66 |
Management Performance
Return On Equity | -0.68 | |||
Return On Asset | -0.37 |
Akili Inc Leadership Team
Elected by the shareholders, the Akili's board of directors comprises two types of representatives: Akili inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Akili. The board's role is to monitor Akili's management team and ensure that shareholders' interests are well served. Akili's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Akili's outside directors are responsible for providing unbiased perspectives on the board's policies.
Carl Gottlieb, Chief Officer | ||
Scott Kollins, Chief Officer | ||
Jacqueline JD, General Officer | ||
Barrie Brian, VP People | ||
Adam MD, Chief Cofounder | ||
Walter II, CoFounder Chairman | ||
Julie DiCarlo, VP Communications | ||
Jonathan David, Chief Officer | ||
Santosh Shanbhag, CFO Treasurer | ||
Matthew MBA, CEO President | ||
Matthew Omernick, CoFounder Officer | ||
Caty Reid, VP Communications | ||
Walter Martucci, CEO CoFounder |
Akili Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Akili a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.68 | |||
Return On Asset | -0.37 | |||
Operating Margin | (28.37) % | |||
Current Valuation | (15.56 M) | |||
Shares Outstanding | 78.73 M | |||
Shares Owned By Insiders | 23.21 % | |||
Shares Owned By Institutions | 61.47 % | |||
Number Of Shares Shorted | 271.35 K | |||
Price To Book | 0.35 X | |||
Price To Sales | 12.31 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Akili Stock
If you are still planning to invest in Akili Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Akili's history and understand the potential risks before investing.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |